BOSTON SCIENTIFIC CORPORATION (BSX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $17.00M; Additional Paid in Capital, Common StockUSD $21.72B; Treasury Stock, ValueUSD $4.32B.
- 2026-06-12: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Treasury Stock, ValueUSD (m).
- 2026-05-19: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Treasury Stock, ValueUSD (m).
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $17.00M; Additional Paid in Capital, Common StockUSD $21.58B; Treasury Stock, ValueUSD $2.25B.
BOSTON SCIENTIFIC CORPORATION Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Shares, Acquired shares | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) shares | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $17.00M | $21.72B | $4.32B | $-304.00M | $7.82B | $24.93B | $25.17B | 303.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-06-12 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-05-19 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 30.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $17.00M | $21.58B | $2.25B | $-398.00M | $6.91B | $25.86B | $26.10B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $17.00M | $21.50B | $2.25B | $-610.00M | $5.57B | $24.23B | $24.47B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $17.00M | $21.42B | $2.25B | $-689.00M | $4.90B | $23.39B | $23.63B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $17.00M | $21.23B | $2.25B | $-722.00M | $4.14B | $22.42B | $22.65B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $17.00M | $21.13B | $2.25B | $-28.00M | $3.35B | $22.21B | $22.45B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $17.00M | $21.06B | $2.25B | $275.00M | $2.67B | $21.77B | $22.00B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $17.00M | $20.96B | $2.25B | $-128.00M | $2.11B | $20.71B | $20.96B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $17.00M | $20.80B | $2.25B | $164.00M | $1.64B | $20.37B | $20.61B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $17.00M | $20.71B | $2.25B | $132.00M | $1.31B | $19.93B | $20.17B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $17.00M | $20.65B | $2.25B | $49.00M | $819.00M | $19.28B | $19.53B | 263.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $17.00M | $20.57B | $2.25B | $231.00M | $315.00M | $18.89B | $19.13B | 263.29M | (m) | $-8.00M | (m) | $4.00M | 3 month · $41.00M 9 month · $141.00M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $17.00M | $20.44B | $2.25B | $208.00M | $-189.00M | $18.23B | $18.48B | 263.29M | (m) | $-28.00M | (m) | $4.00M | 3 month · $44.00M 6 month · $100.00M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $17.00M | $20.36B | $2.25B | $178.00M | $-450.00M | $17.85B | $18.11B | 263.29M | (m) | $-43.00M | (m) | $4.00M | 3 month · $56.00M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $17.00M | $20.29B | $2.25B | $269.00M | $-750.00M | $17.57B | $17.57B | 263.29M | (m) | $-1.00M | (m) | $-1.00M | 12 month · $-157.00M | (m) | (m) | 263.29M |
| 2022-09-30 | $0.00 | $17.00M | $20.22B | $2.25B | $532.00M | $-876.00M | $17.64B | $17.64B | (m) | (m) | $133.00M | (m) | $35.00M | 3 month · $49.00M 9 month · $96.00M | (m) | (m) | 263.29M |
| 2022-06-30 | $0.00 | $17.00M | $20.10B | $2.25B | $433.00M | $-1.05B | $17.25B | $17.25B | (m) | (m) | $106.00M | (m) | $36.00M | 3 month · $34.00M 6 month · $47.00M | (m) | (m) | 263.29M |
| 2022-03-31 | $0.00 | $17.00M | $20.04B | $2.25B | $222.00M | $-1.30B | $16.73B | $16.73B | (m) | (m) | $29.00M | (m) | $36.00M | 3 month · $14.00M | (m) | (m) | 263.29M |
| 2021-12-31 | $0.00 | $17.00M | $19.99B | $2.25B | $263.00M | $-1.39B | $16.62B | $16.62B | (m) | (m) | $93.00M | (m) | $36.00M | 12 month · $-173.00M | (m) | (m) | 263.29M |
| 2021-09-30 | $0.00 | $17.00M | $19.93B | $2.25B | $238.00M | $-1.47B | (m) | $16.46B | (m) | (m) | $88.00M | (m) | $46.00M | 3 month · $13.00M 9 month · $157.00M | (m) | (m) | 263.29M |
| 2021-06-30 | $0.00 | $17.00M | $19.82B | $2.25B | $237.00M | $-1.88B | (m) | $15.94B | (m) | (m) | $136.00M | (m) | $46.00M | 3 month · $9.00M 6 month · $144.00M | (m) | (m) | 263.29M |
| 2021-03-31 | $0.00 | $17.00M | $19.75B | $2.25B | $254.00M | $-2.05B | (m) | $15.72B | (m) | (m) | $134.00M | (m) | $45.00M | 3 month · $135.00M | (m) | (m) | 263.29M |
| 2020-12-31 | $0.00 | $17.00M | $19.73B | $2.25B | $207.00M | $-2.38B | (m) | $15.33B | (m) | (m) | $218.00M | (m) | $47.00M | 12 month · $-76.00M | $36.00M | (m) | 263.29M |
| 2020-09-30 | $0.00 | $17.00M | $19.69B | $1.72B | $151.00M | $-2.57B | (m) | $15.56B | (m) | (m) | $38.00M | (m) | $45.00M | 3 month · $19.00M 9 month · $65.00M | (m) | (m) | 247.57M |
| 2020-06-30 | $0.00 | $17.00M | $19.59B | $1.72B | $131.00M | $-2.40B | (m) | $15.62B | (m) | (m) | $-46.00M | (m) | $45.00M | 3 month · $25.00M 6 month · $47.00M | (m) | (m) | 247.57M |
| 2020-03-31 | (m) | $16.00M | $17.59B | $1.72B | $168.00M | $-2.25B | (m) | $13.80B | (m) | (m) | $-35.00M | (m) | $45.00M | 3 month · $21.00M | (m) | (m) | 247.57M |
| 2019-12-31 | $0.00 | $16.00M | $17.56B | $1.72B | $270.00M | $-2.25B | (m) | $13.88B | (m) | (m) | $142.00M | (m) | $45.00M | 12 month · $-86.00M | $173.00M | (m) | 247.57M |
| 2019-09-30 | (m) | $16.00M | $17.51B | $1.72B | $138.00M | $-6.25B | (m) | $9.70B | (m) | (m) | $-48.00M | (m) | $26.00M | 3 month · $26.00M 9 month · $59.00M | (m) | (m) | 247.57M |
| 2019-06-30 | (m) | $16.00M | $17.42B | $1.72B | $78.00M | $-6.38B | (m) | $9.43B | (m) | (m) | $-46.00M | (m) | $26.00M | 3 month · $19.00M 6 month · $34.00M | (m) | (m) | 247.57M |
| 2019-03-31 | (m) | $16.00M | $17.37B | $1.72B | $87.00M | $-6.53B | (m) | $9.23B | (m) | (m) | $-46.00M | (m) | $26.00M | 3 month · $15.00M | (m) | (m) | 247.57M |
| 2018-12-31 | (m) | $16.00M | $17.35B | $1.72B | $33.00M | $-6.95B | (m) | $8.73B | (m) | (m) | $-53.00M | $0.00 | $25.00M | 12 month · $-3.00M | $111.00M | (m) | 247.57M |
| 2018-09-30 | (m) | $16.00M | $17.30B | $1.72B | $25.00M | $-7.34B | (m) | $8.29B | (m) | (m) | $-74.00M | (m) | $27.00M | 3 month · $7.00M 9 month · $-8.00M | (m) | (m) | 247.57M |
| 2018-06-30 | (m) | $16.00M | $17.23B | $1.72B | $-16.00M | $-7.77B | (m) | $7.74B | (m) | (m) | $-68.00M | $0.00 | $27.00M | 3 month · $-2.00M 6 month · $-15.00M | (m) | (m) | 247.57M |
| 2018-03-31 | (m) | $16.00M | $17.18B | $1.72B | $-128.00M | $-8.33B | (m) | $7.03B | (m) | (m) | $-22.00M | $0.00 | $27.00M | 3 month · $-13.00M | (m) | (m) | 247.57M |
| 2017-12-31 | (m) | $16.00M | $17.16B | $1.72B | $-59.00M | $-8.39B | (m) | $7.01B | (m) | (m) | $-32.00M | $-1.00M | $27.00M | 12 month · $-25.00M | $1.00M | (m) | 247.57M |
| 2017-09-30 | (m) | $16.00M | $17.12B | $1.72B | $-51.00M | $-7.79B | (m) | $7.59B | (m) | (m) | $-33.00M | $-3.00M | $22.00M | 3 month · $8.00M 9 month · $40.00M | (m) | (m) | 247.57M |
| 2017-06-30 | (m) | $16.00M | $17.06B | $1.72B | $-53.00M | $-8.07B | (m) | $7.24B | (m) | (m) | $-58.00M | $-4.00M | $22.00M | (m) | $25.00M | (m) | 247.57M |
| 2017-03-31 | (m) | $16.00M | $17.02B | $1.72B | $-46.00M | $-8.21B | (m) | $7.05B | (m) | (m) | $-71.00M | $-6.00M | $-21.00M | (m) | $47.00M | (m) | 247.57M |
| 2016-12-31 | (m) | $16.00M | $17.01B | $1.72B | $1.00M | $-8.58B | (m) | $6.73B | (m) | (m) | $-79.00M | $-6.00M | $21.00M | 12 month · $0.00 | $107.00M | (m) | 247.57M |
| 2016-09-30 | (m) | $19.00M | $16.98B | $1.72B | $-99.00M | $-8.71B | (m) | $6.48B | (m) | (m) | $-57.00M | (m) | $-10.00M | (m) | $-38.00M | (m) | 247.57M |
| 2016-06-30 | (m) | $18.00M | $16.92B | $1.72B | $-70.00M | $-8.93B | (m) | $6.22B | (m) | (m) | $-59.00M | (m) | $-10.00M | (m) | $-7.00M | (m) | 247.57M |
| 2016-03-31 | (m) | $16.00M | $16.85B | $1.72B | $35.00M | $-8.72B | (m) | $6.46B | (m) | (m) | $-38.00M | (m) | $-10.00M | (m) | $77.00M | (m) | 247.57M |
| 2015-12-31 | (m) | $16.00M | $16.86B | $1.72B | $88.00M | $-8.93B | (m) | $6.32B | (m) | (m) | $-54.00M | $0.00 | $10.00M | 12 month · $0.00 | $152.00M | 248.00M | 247.57M |
| 2015-09-30 | (m) | $16.00M | $16.82B | $1.72B | $81.00M | $-8.79B | (m) | $6.41B | (m) | (m) | $-80.00M | (m) | $-16.00M | (m) | $171.00M | (m) | 247.57M |
| 2015-06-30 | (m) | $16.00M | $16.76B | $1.72B | $104.00M | $-8.59B | (m) | $6.58B | (m) | (m) | $-68.00M | (m) | $-32.00M | (m) | $197.00M | (m) | 247.57M |
| 2015-03-31 | (m) | $16.00M | $16.75B | $1.72B | $142.00M | $-8.69B | (m) | $6.50B | (m) | (m) | $-73.00M | (m) | $-32.00M | (m) | $246.00M | (m) | 247.57M |
| 2014-12-31 | (m) | $16.00M | $16.70B | $1.72B | $144.00M | $-8.69B | (m) | $6.46B | (m) | (m) | $-38.00M | (m) | $37.00M | (m) | $219.00M | 248.00M | 247.57M |
| 2014-09-30 | (m) | $16.00M | $16.68B | $1.72B | $110.00M | $-8.39B | (m) | $6.70B | (m) | 9 month · 10.00M | $-39.00M | (m) | $-20.00M | (m) | $169.00M | (m) | 247.57M |
| 2014-06-30 | (m) | $16.00M | $16.64B | $1.72B | $42.00M | $-8.43B | (m) | $6.54B | (m) | 6 month · 10.00M | $-24.00M | (m) | $-20.00M | (m) | $85.00M | (m) | 247.57M |
| 2014-03-31 | (m) | $16.00M | $16.60B | $1.72B | $72.00M | $-8.44B | (m) | $6.53B | (m) | 3 month · 10.00M | $-22.00M | (m) | $-20.00M | (m) | $112.00M | (m) | 247.57M |
| 2013-12-31 | (m) | $16.00M | $16.58B | $1.59B | $106.00M | $-8.57B | (m) | $6.54B | (m) | (m) | $-16.00M | (m) | $19.00M | (m) | $141.00M | 238.00M | 238.01M |
| 2013-09-30 | (m) | $16.00M | $16.54B | $1.37B | $56.00M | $-8.68B | (m) | $6.56B | (m) | 3 month · 7.00M 9 month · 32.00M | $-18.00M | (m) | $-41.00M | (m) | $113.00M | (m) | 219.06M |
| 2013-06-30 | (m) | $16.00M | $16.47B | $1.29B | $84.00M | $-8.67B | (m) | $6.60B | (m) | 3 month · 13.00M 6 month · 26.00M | $-28.00M | (m) | $-41.00M | (m) | $150.00M | (m) | 212.29M |
| 2013-03-31 | (m) | $16.00M | $16.44B | $1.19B | $45.00M | $-8.80B | (m) | $6.50B | (m) | 3 month · 13.00M | $-23.00M | (m) | $-41.00M | (m) | $106.00M | (m) | 199.75M |
| 2012-12-31 | (m) | $15.00M | $16.43B | $1.09B | $-33.00M | $-8.45B | (m) | $6.87B | (m) | (m) | $-26.00M | (m) | $-41.00M | (m) | $34.00M | 187.00M | 186.64M |
| 2012-09-30 | (m) | $15.00M | $16.43B | $992.00M | $-112.00M | $-8.51B | (m) | $6.83B | (m) | 3 month · 46.00M 9 month · 87.00M | $-49.00M | (m) | $-32.00M | (m) | $-34.00M | (m) | 168.70M |
| 2012-06-30 | $0.00 | $15.00M | $16.39B | $742.00M | $-87.00M | $-7.85B | (m) | $7.73B | (m) | 3 month · 18.00M 6 month · 41.00M | $-51.00M | (m) | $-32.00M | (m) | (m) | (m) | 122.46M |
| 2012-03-31 | $0.00 | $15.00M | $16.36B | $630.00M | $-79.00M | $-4.27B | (m) | $11.40B | (m) | 3 month · 23.00M | $-32.00M | (m) | $-32.00M | (m) | (m) | (m) | 104.45M |
| 2011-12-31 | $0.00 | $15.00M | $16.35B | $492.00M | $-138.00M | $-4.38B | (m) | $11.35B | (m) | (m) | $-58.00M | (m) | $-32.00M | (m) | $-48.00M | 82.00M | 81.95M |
| 2011-09-30 | $0.00 | $15.00M | $16.32B | $192.00M | $-132.00M | $-4.49B | (m) | $11.52B | (m) | 3 month · 30.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $0.00 | $15.00M | $16.28B | (m) | $-123.00M | $-4.63B | (m) | $11.54B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $0.00 | $15.00M | $16.25B | (m) | $-119.00M | $-4.78B | (m) | $11.37B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | $15.00M | $16.23B | (m) | $-129.00M | $-4.82B | (m) | $11.30B | (m) | (m) | $-50.00M | (m) | $14.00M | (m) | $-65.00M | 0.00 | 0.00 |
| 2010-09-30 | $0.00 | $15.00M | $16.20B | (m) | $-117.00M | $-5.06B | (m) | $11.04B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $0.00 | $15.00M | $16.16B | (m) | $-37.00M | $-5.25B | (m) | $10.89B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | $0.00 | $15.00M | $16.13B | (m) | $-18.00M | $-5.35B | (m) | $10.78B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $0.00 | $15.00M | $16.09B | (m) | $-43.00M | $-3.76B | (m) | $12.30B | (m) | (m) | $8.00M | (m) | $14.00M | (m) | $-37.00M | (m) | 0.00 |
| 2009-09-30 | $0.00 | $15.00M | $16.06B | (m) | $-93.00M | $-2.68B | (m) | $13.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | $0.00 | $15.00M | $16.01B | (m) | $-22.00M | $-2.59B | (m) | $13.41B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $0.00 | $15.00M | $15.94B | (m) | $-53.00M | $-2.73B | (m) | $13.17B | (m) | (m) | $-13.00M | (m) | $14.00M | (m) | $-26.00M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |